Many of these genes include transcription factors that are well known to modulate AML differentiation such as c-myc and c-myb which are downregulated and CEBP/β, CEBP/δ, egr-1, mafB, fos, and jun that are upregulated. This evidence concerns the gene CEBPA and acute myeloid leukemia.